As on Thursday, Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) got off with the flyer as it spiked 0.67% to $12.08, before settling in for the price of $12.0 at the close. Taking a more long-term approach, AMLX posted a 52-week range of $2.60-$16.96.
The Healthcare sector firm’s twelve-monthly sales growth has been -78.71% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -78.71%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 65.04%. This publicly-traded company’s shares outstanding now amounts to $109.77 million, simultaneously with a float of $91.68 million. The organization now has a market capitalization sitting at $1.33 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.41, while the 200-day Moving Average is $9.05.
Amylyx Pharmaceuticals Inc (AMLX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Amylyx Pharmaceuticals Inc’s current insider ownership accounts for 16.52%, in contrast to 94.74% institutional ownership. According to the most recent insider trade that took place on Dec 23 ’25, this organization’s Director bought 8,100 shares at the rate of 12.45, making the entire transaction reach 100,845 in total value, affecting insider ownership by 63,100. Preceding that transaction, on Dec 01 ’25, Company’s Chief Medical Officer sold 6,580 for 14.35, making the whole transaction’s value amount to 94,418. This particular insider is now the holder of 175,756 in total.
Amylyx Pharmaceuticals Inc (AMLX) Earnings and Revenue Records
Amylyx Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 65.04% and is forecasted to reach -1.15 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 33.77% through the next 5 years, which can be compared against the -78.71% growth it accomplished over the previous five years trading on the market.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Trading Performance Indicators
Let’s observe the current performance indicators for Amylyx Pharmaceuticals Inc (AMLX). It’s Quick Ratio in the last reported quarter now stands at 13.70.
In the same vein, AMLX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.80, a figure that is expected to reach -0.35 in the next quarter, and analysts are predicting that it will be -1.15 at the market close of one year from today.
Technical Analysis of Amylyx Pharmaceuticals Inc (AMLX)
Through scrutinizing the latest numbers posted by the [Amylyx Pharmaceuticals Inc, AMLX], it can be observed that its last 5-days Average volume of 1.36 million was better the volume of 1.33 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 32.55% While, its Average True Range was 36.28.
Raw Stochastic average of Amylyx Pharmaceuticals Inc (AMLX) in the period of the previous 100 days is set at 47.84%, which indicates a major rise in contrast to 22.29% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.59 that was lower than 0.76 volatility it exhibited in the past 100-days period.
